Wedbush Starts La Jolla Pharma (LJPC) at Outperform; Analyst Comments
Tweet Send to a Friend
Wedbush initiated coverage on La Jolla Pharma (NASDAQ: LJPC) with an Outperform rating and price target of $27.00. Analyst Liana ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
